Challenges and Innovations in 3D Printed Bio-organs and Their Materials
摘要
The advent of 3D printing technology has revolutionized various sectors, particularly medicine, by introducing ground-breaking possibilities for creating bio-organs. In healthcare, 3D printing is used to create living cells, tissues, and organs for tissue engineering and regenerative medicine. The COVID-19 pandemic significantly impacted the healthcare sector, increasing the demand for critical care equipment and medical devices, including organs, due to advances in medical treatments and longer lifespans of the elderly. Traditionally, vaccines, drugs, and cosmetics are tested using animal models to evaluate efficacy and safety before human trials. However, 3D bioprinting technology offers great potential to develop robust 3D models of live human tissues, providing an alternative to animal models for drug testing. This chapter explores the multifaceted challenges and innovative strides in 3D printed bio-organs and their materials. It begins with an overview of the historical development and significant potential of bio-organ printing, followed by an explanation of fundamental 3D printing technologies and the materials used, such as biocompatible polymers, hydrogels, and composite materials. The chapter also addresses critical challenges, including biological compatibility, vascularization, mechanical properties, and ethical and regulatory issues. Additionally, it examines emerging materials, stem cell technology, organ-on-a-chip systems, robotic-assisted bioprinting, and AI-based healthcare, highlighting ongoing innovations and research shaping the future of 3D printed bio-organs. Cutting-edge advancements in bio-ink formulations and multi-material printing techniques are transforming the landscape, enabling the fabrication of more complex and functional tissues. This comprehensive analysis aims to provide readers with a thorough understanding of the current landscape, challenges, and innovative developments in 3D printed bio-organs, offering a glimpse into the future of personalized medicine and regenerative healthcare.